Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126975871 | 12697587 | 1 | I | 20160823 | 20160830 | 20160830 | EXP | PHHY2016VE118167 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160830 | MD | VE | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126975871 | 12697587 | 1 | PS | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | 1200 MG, QD (STRENGTH: 600 MG) | 21014 | 1200 | MG | QD | |||||||
| 126975871 | 12697587 | 2 | SS | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | 900 MG, QD (600 MG IN THE MORNING AND 300 MG IN THE NIGHT) | 21014 | 900 | MG | QD | |||||||
| 126975871 | 12697587 | 3 | SS | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | UNK UNK, QD | 21014 | QD | |||||||||
| 126975871 | 12697587 | 4 | SS | TRILEPTAL | OXCARBAZEPINE | 1 | 21014 | ||||||||||||
| 126975871 | 12697587 | 5 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | Y | 0 | TABLET | |||||||||
| 126975871 | 12697587 | 6 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Y | 0 | TABLET | ||||||||||
| 126975871 | 12697587 | 7 | SS | OXICODAL | OXCARBAZEPINE | 1 | Unknown | 1200 MG, QD (600 MG OR 1200 MG A DAY) | U | 0 | 1200 | MG | QD | ||||||
| 126975871 | 12697587 | 8 | SS | OXICODAL | OXCARBAZEPINE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126975871 | 12697587 | 1 | Cerebral disorder |
| 126975871 | 12697587 | 2 | Seizure |
| 126975871 | 12697587 | 3 | Cerebral disorder |
| 126975871 | 12697587 | 4 | Seizure |
| 126975871 | 12697587 | 5 | Cerebral disorder |
| 126975871 | 12697587 | 6 | Seizure |
| 126975871 | 12697587 | 7 | Cerebral disorder |
| 126975871 | 12697587 | 8 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126975871 | 12697587 | OT |
| 126975871 | 12697587 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126975871 | 12697587 | Drug dependence | |
| 126975871 | 12697587 | Drug ineffective | |
| 126975871 | 12697587 | Eye injury | |
| 126975871 | 12697587 | Eyelid injury | |
| 126975871 | 12697587 | Face injury | |
| 126975871 | 12697587 | Head injury | |
| 126975871 | 12697587 | Mouth injury | |
| 126975871 | 12697587 | Oral discomfort | |
| 126975871 | 12697587 | Oral mucosal blistering | |
| 126975871 | 12697587 | Product use issue | |
| 126975871 | 12697587 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |